84 related articles for article (PubMed ID: 21103615)
1. Tumors in the lung--morphologic features and the challenge of integrating biomarker signatures into diagnostics.
Vollmer E; Schultz H; Stellmacher F; Kähler D; Abdullah M; Galle J; Lang DS; Goldmann T
Rom J Morphol Embryol; 2010; 51(4):607-14. PubMed ID: 21103615
[TBL] [Abstract][Full Text] [Related]
2. Approach to the diagnosis of neuroendocrine lung neoplasms: variabilities and pitfalls.
Hammar SP
Semin Thorac Cardiovasc Surg; 2006; 18(3):183-90. PubMed ID: 17185177
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary approach in diagnosis of lung carcinoma.
Kontic M; Stojsic J; Kacar-Kukric V; Jekic B; Bunjevacki V
Exp Oncol; 2010 Jul; 32(2):111-3. PubMed ID: 20693974
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases.
Cassoni P; Daniele L; Maldi E; Righi L; Tavaglione V; Novello S; Volante M; Scagliotti GV; Papotti M
Histopathology; 2009 Jul; 55(1):20-7. PubMed ID: 19614763
[TBL] [Abstract][Full Text] [Related]
7. Epithelial tumors of the lung.
Gould VE; Warren WH
Chest Surg Clin N Am; 2000 Nov; 10(4):709-28. PubMed ID: 11091921
[TBL] [Abstract][Full Text] [Related]
8. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
Ibe T; Shimizu K; Nakano T; Kakegawa S; Kamiyoshihara M; Nakajima T; Kaira K; Takeyoshi I
J Surg Oncol; 2010 Jul; 102(1):11-7. PubMed ID: 20578072
[TBL] [Abstract][Full Text] [Related]
9. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of neural-cadherin in pulmonary epithelial tumours.
Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
[TBL] [Abstract][Full Text] [Related]
11. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
[TBL] [Abstract][Full Text] [Related]
12. Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.
Sturm N; Lantuéjoul S; Laverrière MH; Papotti M; Brichon PY; Brambilla C; Brambilla E
Hum Pathol; 2001 Sep; 32(9):918-25. PubMed ID: 11567220
[TBL] [Abstract][Full Text] [Related]
13. Large cell/neuroendocrine carcinoma.
Gollard R; Jhatakia S; Elliott M; Kosty M
Lung Cancer; 2010 Jul; 69(1):13-8. PubMed ID: 20133008
[TBL] [Abstract][Full Text] [Related]
14. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
[TBL] [Abstract][Full Text] [Related]
15. miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.
Del Vescovo V; Cantaloni C; Cucino A; Girlando S; Silvestri M; Bragantini E; Fasanella S; Cuorvo LV; Palma PD; Rossi G; Papotti M; Pelosi G; Graziano P; Cavazza A; Denti MA; Barbareschi M
Am J Surg Pathol; 2011 Feb; 35(2):268-75. PubMed ID: 21263248
[TBL] [Abstract][Full Text] [Related]
16. Lung carcinoma metastatic to the ovary: a clinicopathologic study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis.
Irving JA; Young RH
Am J Surg Pathol; 2005 Aug; 29(8):997-1006. PubMed ID: 16006793
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
Dacic S
Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy.
Howe MC; Chapman A; Kerr K; Dougal M; Anderson H; Hasleton PS
Histopathology; 2005 Feb; 46(2):195-201. PubMed ID: 15693892
[TBL] [Abstract][Full Text] [Related]
20. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
